You are here
DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm
SAN FRANCISCO, April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in Diplomat Pharmacy, Inc. (NYSE: DPLO) of the pending securities class action and the April 25, 2019 Lead Plaintiff deadline. If you purchased or otherwise acquired Diplomat Pharmacy securities between February 26, 2018 and February 21, 2019 (the "class period") and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information about the case:
or contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing
According to the complaint, during the class period Defendants misled investors about Diplomat's success in integrating and growing its pharmacy benefit management ("PBM") business.
On February 22, 2019, Defendants' announced they delayed releasing 2018 financial results, expected to record PBM-related impairment charges totaling approximately $630 million, and withdrew preliminary 2019 full-year outlook provided in January 2019.
This news drove the price of Diplomat shares down $7.59, or down about 56%, to close at $5.87 that day.
On March 14, 2019 Diplomat's Chief Financial Officer resigned, driving the price of Diplomat shares down about 13.5%.
"We're focused on investors' losses, whether Defendants' statements about Diplomat's core PBM business may have misled investors, and circumstances surrounding the CFO's departure," said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Diplomat should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email DPLO@hbsslaw.com.
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 78 attorneys in 9 offices across the country. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Reed Kathrein, 510-725-3000
View original content to download multimedia:http://www.prnewswire.com/news-releases/dplo-class-action-reminder-hagens-berman-reminds-diplomat-pharmacy-dplo-of-securities-class-action-encourages-investors-to-contact-the-firm-300832316.html
SOURCE Hagens Berman Sobol Shapiro LLP